✦ LIBER ✦

Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses

✍ Scribed by Kieber-Emmons, Thomas; Luo, Ping; Qiu, Jianping; Chang, Tylis Y.; O, Insug; Blaszczyk-Thurin, Magdalena; Steplewski, Zenon

Book ID: 109471979
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 886 KB
Volume: 17
Category: Article
ISSN: 1087-0156
DOI: 10.1038/10870

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer vaccine with mimotopes of tumor-a

Cancer vaccine with mimotopes of tumor-associated carbohydrate antigens

✍ Danuta Kozbor 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 278 KB

Induction of IgG antibodies against the

Induction of IgG antibodies against the GD2 carbohydrate tumor antigen by vaccination with peptide mimotopes

✍ Angelika B. Riemer; Elisabeth Förster-Waldl; Kira H. Brämswig; Arnold Pollak; Ch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

Modulation of anti-tumor immune response

Modulation of anti-tumor immune responses by peptide vaccination

✍ R.E.M. Toes; R. Offringa; E. van der Voort; W.M. Kast; C.J.M. Melief 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Anti-tumor immune responses and tumor re

Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope

✍ Sherev Tumenjargal; Sylke Gellrich; Thomas Linnemann; J. Marcus Muche; Ansgar Lu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB 👁 1 views

Mimotopes of tumor-associated T-cell epi

Mimotopes of tumor-associated T-cell epitopes for cancer vaccines determined with combinatorial peptide libraries

✍ Tumenjargal Sherev; Karl-Heinz Wiesmüller; Peter Walden 📂 Article 📅 2003 🏛 Humana Press Inc 🌐 English ⚖ 251 KB

Construction of cancer vaccines with car

Construction of cancer vaccines with carbohydrate and protein (peptide) tumor antigens

✍ Philip O Livingston 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 908 KB

Tumor vaccinology is as old as immunological thought and as young as our rapidly evolving understanding of antigen processing and presentation. The recent availability of carbohydrate and peptide tumor antigens suitable for vaccine construction, conjugate and recombinant vector technologies capable